AI follow-up for DEL instead of resynthesis:

Faster results,
More diverse leads,
95% cost savings.

About DeepDELve

DeepDELve, developed since early 2019, is a highly-optimised deep learning pipeline for virtual screening. It allows DEL teams to identify target-binders within online catalogues instead of expensively resynthesising library hits. The pipeline yields more numerous, more diverse leads than resynthesis, faster and at vastly lower cost.

DEL screens often contain millions of hits. By leveraging all of them, DeepDELve extracts maximum value and allows the quick and inexpensive exploration of new chemical space. The pipeline can be integrated with any standard DEL collection.

24
hours
To train models and search all commercial catalogues (including Enamine REAL lead-like space).
3
days
To receive the first catalogue compounds.
95%
less
Spent on compound acquisition, compared to resynthesis.

Partners

News

25 August 2021
Cambridge Molecular announces the release of DeepDELve 2
All News
background picture

Contact Us

general@cambridgemolecular.ai

Cambridge Molecular Ltd
The Bradfield Centre
184 Cambridge Science Park
Cambridge CB4 0GA
England

© 2019 Cambridge Molecular Ltd